Veni, vidi, vici

 WestRock Announces Consent Solicitation

Retrieved on: 
수요일, 9월 20, 2023
Forest Products, Packaging, Natural Resources, Manufacturing, Communication, Smurfit Kappa, Coronavirus, Accounting, Pandemic, Risk, Government, Consent, National Storage, Policy, OR, Attention, Epidemic, Power, Security (finance), Safety, Uncertainty, COVID-19, WestRock, Dynamic consent, Holder, Expiration, Cyclone, Eric Holder, SKG, Prospectus, ANY, United Kingdom, Health, Veni, vidi, vici, Solicitation, Property management, Mergers and acquisitions, Indenture, Note, Issuer

WestRock Company (“WestRock”) announced today that its wholly-owned subsidiary WRKCo Inc. (the “Issuer”) commenced a consent solicitation through which it is soliciting consents (“Consents”) from registered holders (“Holders”) of the Notes (the “Consent Solicitation”) to amend certain terms of the indentures governing the respective Notes (each, an “Indenture” and together, the “Indentures”).

Key Points: 
  • WestRock Company (“WestRock”) announced today that its wholly-owned subsidiary WRKCo Inc. (the “Issuer”) commenced a consent solicitation through which it is soliciting consents (“Consents”) from registered holders (“Holders”) of the Notes (the “Consent Solicitation”) to amend certain terms of the indentures governing the respective Notes (each, an “Indenture” and together, the “Indentures”).
  • The terms and conditions of the Consent Solicitation are set forth in a consent solicitation statement dated as of September 20, 2023 (as it may be amended and supplemented from time to time, the “Consent Solicitation Statement”).
  • The Consent Solicitation will expire at 5:00 p.m., New York time, on September 26, 2023, unless the Consent Solicitation is extended or earlier terminated by the Issuer for any or all series of the Notes in its sole discretion (the “Expiration Time”).
  • The Consent Solicitation is only being made pursuant to the terms of the Consent Solicitation Statement.

EQS-News: Luminis Finance Public Limited Company : NOTICE OF AMENDMENT

Retrieved on: 
수요일, 9월 6, 2023
Transfer, Effective date, Dealer, Purchase and sale agreement, SACHS, Rights, Stock, Principal, Trust instrument, Consent, Conduct, Meeting, The Santa Clause 3: The Escape Clause, AAX (Atom Asset Exchange), Sale, Business, Trust, Registrar, Party, IRS tax forms, Form, Swap, BNY, Restatements of the Law, Polaris, Holder in due course, Vertigo, Clause, Initial, Forward contract, Series, Deed, Employment Relations Act 1999, Veni, vidi, vici, Security (finance), Rare-earth element, Property management, Lease, Life insurance, Vendor, Clearstream, Custodian, Amendment, Trustee, Molesworth Street, Amend, Note, Euroclear, Issuer

The amended terms of the Notes are as set out in Schedule C (Amended and Restated Pricing Supplement) to this Deed.

Key Points: 
  • The amended terms of the Notes are as set out in Schedule C (Amended and Restated Pricing Supplement) to this Deed.
  • In addition, the provisions of the General Definitions relating to construction of certain references shall apply to this Deed as if set out herein.
  • “Holder Notification” means a notice notifying the Holders of the Asset Exchange and Amendments, substantially in the form set out in Schedule B (Form of Holder Notification).
  • “Initial Charged Asset 2” has the meaning given to it in the Amended and Restated Pricing Supplement.

Former, current, and prospective Volkswagen or Audi customers may be included in a $3.5 million Class Action Settlement

Retrieved on: 
목요일, 1월 19, 2023
Shift, Dubrovka, Dubrovsky Settlement Administrative Okrug, Dubrovsky District, Bryansk Oblast, Veni, vidi, vici, Burnham v. Superior Court of California, Superior court, LLP, Client First Settlement Funding, Court, Volkswagen Group, Volkswagen, Incident, Settlement, Nationwide, SPI, Summons, Insurance, Pharmaceutical industry, Audi

The lawsuit arises from an alleged data security incident (the "Incident") involving the personal information ("PI") and sensitive personal information ("SPI") of certain current, former, and prospective Volkswagen and Audi customers.

Key Points: 
  • The lawsuit arises from an alleged data security incident (the "Incident") involving the personal information ("PI") and sensitive personal information ("SPI") of certain current, former, and prospective Volkswagen and Audi customers.
  • Who is included in the settlement?
  • If you do not wish to submit a claim, you may: (1) do nothing; (2) object to the settlement; or (3) exclude yourself from the Settlement Class.
  • If you object to the settlement or do nothing, you are choosing to stay in the Settlement Class.

Class Action Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Silvergate Capital Corporation Investors of Securities Fraud Class Action Lawsuit

Retrieved on: 
월요일, 1월 16, 2023
News, COPY, Insurance, District court, Bear's Cave (Erpfingen), FTX, Bears' Cave, NYSE, LLP, Lead, Silvergate Media, Court, Veni, vidi, vici, Private investigator, Cryptocurrency

RADNOR, Pa., Jan. 16, 2023 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of California against Silvergate Capital Corporation (“Silvergate”) ( NYSE: SI ).

Key Points: 
  • RADNOR, Pa., Jan. 16, 2023 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of California against Silvergate Capital Corporation (“Silvergate”) ( NYSE: SI ).
  • The action charges Silvergate with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company’s business, operations, and prospects.
  • Kessler Topaz Meltzer & Check, LLP encourages Silvergate investors who have suffered significant losses to contact the firm directly to acquire more information.
  • The class action complaint against Silvergate, captioned Rosa v. Silvergate Capital Corporation, et al.

Attention Shareholders: Kessler Topaz Meltzer & Check, LLP Reminds Shareholders of Securities Fraud Class Action Lawsuit Filed against Silvergate Capital Corporation and Encourages Investors to Contact the Firm

Retrieved on: 
화요일, 1월 10, 2023
Legal, Professional Services, News, COPY, Insurance, District court, Bear's Cave (Erpfingen), FTX, Bears' Cave, NYSE, LLP, Lead, Silvergate Media, Court, Veni, vidi, vici, Private investigator, Cryptocurrency

The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of California against Silvergate Capital Corporation (“Silvergate”) ( NYSE: SI ).

Key Points: 
  • The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of California against Silvergate Capital Corporation (“Silvergate”) ( NYSE: SI ).
  • The action charges Silvergate with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company’s business, operations, and prospects.
  • Kessler Topaz Meltzer & Check, LLP encourages Silvergate investors who have suffered significant losses to contact the firm directly to acquire more information.
  • The class action complaint against Silvergate, captioned Rosa v. Silvergate Capital Corporation, et al.

Kessler Topaz Meltzer & Check, LLP Announces a Securities Fraud Class Action Filed Against Silvergate Capital Corporation

Retrieved on: 
금요일, 1월 6, 2023
FTX, COPY, Veni, vidi, vici, Silvergate Media, District court, Lead, News, Bears' Cave, Bear's Cave (Erpfingen), NYSE, LLP, Court, Insurance, Private investigator, Cryptocurrency

RADNOR, Pa., Jan. 06, 2023 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of California against Silvergate Capital Corporation (“Silvergate”) ( NYSE: SI ).

Key Points: 
  • RADNOR, Pa., Jan. 06, 2023 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of California against Silvergate Capital Corporation (“Silvergate”) ( NYSE: SI ).
  • The action charges Silvergate with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company’s business, operations, and prospects.
  • Kessler Topaz Meltzer & Check, LLP encourages Silvergate investors who have suffered significant losses to contact the firm directly to acquire more information.
  • The class action complaint against Silvergate, captioned Rosa v. Silvergate Capital Corporation, et al.

AB Science has received approval from the U.S. Food and Drug Administration (FDA) to initiate the confirmatory Phase 3 study with masitinib in the treatment of progressive multiple sclerosis

Retrieved on: 
목요일, 12월 29, 2022
Multiple, Multiple sclerosis, BTK, MD, Clinical trial, MS, Neurology, ANSM, Disease, Patient, NSPM, Microglia, B cell, Veni, vidi, vici, FOOD, Safety, Pathology, University, FDA, EDSS, PPMS, University of Lille, DRUG, Cell, Neurodegeneration, Randomness, Pharmaceutical industry, Masitinib

AB SCIENCE HAS RECEIVED APPROVAL FROM THE U.S. FOOD AND DRUG ADMINISTRATION (FDA) TO INITIATE THE CONFIRMATORY PHASE 3 STUDY WITH MASITINIB IN THE TREATMENT OF PROGRESSIVE MULTIPLE SCLEROSIS

Key Points: 
  • AB SCIENCE HAS RECEIVED APPROVAL FROM THE U.S. FOOD AND DRUG ADMINISTRATION (FDA) TO INITIATE THE CONFIRMATORY PHASE 3 STUDY WITH MASITINIB IN THE TREATMENT OF PROGRESSIVE MULTIPLE SCLEROSIS
    This decision follows authorizations received from several European countries, including the French Agency (ANSM).
  • This is a randomized, double-blind, Phase 3 study to evaluate the safety and efficacy of masitinib 4.5 mg/kg/day in patients with primary progressive multiple sclerosis (PPMS) or non-active secondary progressive multiple sclerosis (nSPMS).
  • The primary endpoint of the study is the effect of masitinib on time to confirmed disability progression.
  • Efficacy and Safety of Masitinib in Progressive Forms of Multiple Sclerosis: A Randomized, Phase 3, Clinical Trial.

Hagens Berman Promotes Six Attorneys – Including Five Women – to Partner in 2023

Retrieved on: 
수요일, 1월 4, 2023
Women, Consumer, Professional Services, Legal, DEI (Diversity, Equity and Inclusion), Ignition, Oxford-Whitney Streets Historic District, United States Court of Appeals for the Third Circuit, Veni, vidi, vici, Ezetimibe, HIV, Bosentan, Broiler, Employment, Nasdaq Market Makers Antitrust Litigation, Privacy, Human, Celecoxib, Eye, Adalimumab, Patent, Insulin, Woman, Pharmaceutical industry

Hagens Berman, a global plaintiffs’ class-action law firm, promoted six attorneys – five of whom are women – to partner in 2023, the firm’s 30th year of fighting for the rights of those who need it most.

Key Points: 
  • Hagens Berman, a global plaintiffs’ class-action law firm, promoted six attorneys – five of whom are women – to partner in 2023, the firm’s 30th year of fighting for the rights of those who need it most.
  • “We know that what makes any team strong is its players, and we’re delighted to continue to strengthen our roster of extraordinary partners,” Berman said.
  • The six attorneys come from across four of the firm’s offices, representing exceptional lawyering across a variety of practice areas.
  • Hannah Brennan focuses on drug pricing, consumer access to medications, healthcare fraud, antitrust and patent fraud at the firm’s Boston office.

FIGS 96 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess Of $100,000 of Deadline in Class Action Lawsuits Against FIGS, Inc. - FIGS

Retrieved on: 
토요일, 12월 31, 2022
Class Action Lawsuit, Professional Services, Legal, Veni, vidi, vici, Register, EBITDA, Central District, City, District court, News, NYSE, Special warfare combatant-craft crewmen, Firefighter, Court, Prospectus, KSF, Security (finance)

These actions are pending in the United States District Court for the Central District of California.

Key Points: 
  • These actions are pending in the United States District Court for the Central District of California.
  • On this news, the price of FIGS’ shares plummeted, falling approximately 25% to close at $9.64 per share.
  • A subsequent case was filed, City Of Hallandale Beach Police Officers And Firefighters Personnel Retirement Trust v. Figs, Inc., et al., No.
  • About Kahn Swick & Foti, LLC
    KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation’s premier boutique securities litigation law firms.

Secure Transfusion Solutions Granted its First Biologics License Application Approval

Retrieved on: 
화요일, 1월 3, 2023
Licensure, Quality of life, Patient, Trust, Food, Hope, STS, World Blood Donor Day, Bleeding, Center for Biologics Evaluation and Research, Blood, Veni, vidi, vici, FDA, MD, BLA, Multimedia, Collection, Cancer, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Hospital, Pharmaceutical industry, Blood product, Research

We celebrate this important milestone of receiving the first BLA approval and its impact for the blood supply across the US and for our company."

Key Points: 
  • We celebrate this important milestone of receiving the first BLA approval and its impact for the blood supply across the US and for our company."
  • Secure Transfusion Solutions (STS) is a life sciences company pioneering innovative methods to overcome the nation's growing blood and platelet shortage.
  • Its purpose is to restore hope, build trust and improve quality of life by increasing patient access to readily available and safe transfusion solutions.
  • By partnering with STS, hospital systems increase confidence in the sourcing of blood components, better preparing them to meet evolving patient transfusion needs.